What sector does Jupiter Life Line Hosp L belong to?

Jupiter Life Line Hosp L operates in the Healthcare sector, specifically the Hospital industry, and is listed on the NSE.

What is the current share price of JLHL?

As of the latest available quote, JLHL traded at ₹279.15. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of JLHL?

Jupiter Life Line Hosp L has a price-to-earnings (P/E) ratio of about 48.80. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of JLHL?

The market capitalisation of Jupiter Life Line Hosp L is approximately ₹9,151 Cr.

Is Jupiter Life Line Hosp L profitable?

For its latest reported financial year, Jupiter Life Line Hosp L recorded a net profit margin of about 12.93%.

Does JLHL pay a dividend?

Jupiter Life Line Hosp L does not currently show a dividend yield in our data.

What is the return on equity (ROE) of JLHL?

Jupiter Life Line Hosp L has a return on equity (ROE) of about 13.10%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of JLHL?

Over the past 52 weeks, JLHL has traded between a low of ₹235.60 and a high of ₹340.00.

Jupiter Life Line Hosp L

JLHL NSE Healthcare Hospital

Microcap 250

₹279.15

-0.66%

Delayed · cached 15 min

Fair value analysis

JLHL

Jupiter Life Line Hosp L

₹281.00

Close used for this calculation

₹186.92Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

44/100

Profitability21/25

Returns6/25

Balance Sheet9/25

Efficiency8/25

Growth12/25

Average

Quality radar

Consensus fair value

₹186.92

Above FV

▼ -33.5% against the close used

Model range ₹78.85 – ₹303.70

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹78.85Fair value₹186.92Bull₹303.70

FairClose

52-week traded range

52W low ₹239.9852W high ₹332.40

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Jupiter Life Line Hosp L closed at ₹281.00, 50.3% above the consensus fair value of ₹186.92 drawn from 9 valuation models.

Financial DNA score 44/100 — Average. P/E of 47.9x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹117.51

-58.2%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹78.85

-71.9%

√(22.5 × EPS × BVPS)

EPS=5.92, BVPS=46.68 · outside Graham range (P/E 47.9, P/B 6) — asset-light, treat as a rough floor

Graham Formula

₹266.61

-5.1%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=20%, FD=7%

P/E Fair Value

₹303.70

+8.1%

EPS × 51.3x (sector P/E)

EPS=5.92, Sector P/E=51.3x

Peter Lynch (PEG)

₹148.00

-47.3%

EPS × Growth% (PEG = 1 is fair)

EPS=5.92, g=25%

EV/EBITDA

₹220.29

-21.6%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=4.31B

Book Value (P/B)

₹82.85

-70.5%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=46.68, ROE=13.1%, g=6%, r=10%

Reverse DCF

₹281.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 18.8% | Historical: 25%

Margin of Safety

₹143.75

-48.8%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=191.67, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer